senseerahealth.com
Get leads like Senseerahealth — and thousands more
Build targeted lists by tech stack, and more
Senseera: The Chromatin Liquid Biopsy Play
A $3.6M revenue biotech betting that cell-free chromatin reveals more than ctDNA
Liquid biopsy is dominated by circulating tumor DNA (ctDNA), but Senseera is betting the farm that the real clinical gold lies in the fragmented chromatin floating in our blood. They're mapping genome-wide expression to predict disease stage and therapeutic response, starting with the liver and expanding outwards.
"They aren't chasing DNA mutations; they're decoding the genomic 'noise' that reveals active disease states in real-time."
The Technology: Beyond DNA Sequencing
Senseera’s core IP revolves around 'first-in-class liquid biopsy based on cell-free chromatin analysis.' While competitors like Guardant Health look for specific mutations in cfDNA, Senseera generates quantitative genome expression maps. This allows them to uncover not just *what* mutations exist, but *how* the disease is behaving—specifically its stage and likely response to therapy. It’s a shift from static snapshots to dynamic monitoring.
The Business: Bootstrapped Scale
With a lean team of 23 employees and $3.6M in revenue, Senseera is operating with impressive efficiency for a pre-revenue biotech. However, their traffic metrics are non-existent, suggesting they are in a stealth or clinical validation phase rather than a commercial sales cycle. Their $8.44M in funding is modest for diagnostics, indicating they are likely seeking Series A capital to scale clinical trials beyond their liver-focused proof-of-concept.
The biotech stack reveals a pragmatic engineering approach. They rely on WordPress for their public-facing site—a common choice for early-stage companies prioritizing speed over custom builds—powered by jQuery and Tailwind CSS. It’s a functional, if unpolished, digital presence for a company claiming to transform diagnostics.
- The 'Sense Era': A play on words that highlights the sensor-based nature of their chromatin analysis.
- Liver-first strategy: Targeting hepatocellular carcinoma (HCC) offers a massive TAM with limited screening options.
- Leadership depth: A 5-person C-suite indicates a focus on operational rigor from day one.
The Verdict: A High-Risk, High-Reward Diagnostic
If chromatin analysis proves superior to ctDNA, Senseera could command a massive premium in the oncology diagnostics market.
What tech stack does Senseerahealth use?
How much traffic does Senseerahealth get?
Traffic & Engagement
What keywords does Senseerahealth rank for?
1 keywordsHow is Senseerahealth's SEO?
Meta Tags
Senseera - Transforming Diagnostics with Cell-State Biomarkers from Blood and AI algorithms
First-in-class liquid biopsy based on cell-free chromatin analysis, generating quantitativegenome expression maps to uncover disease stage and therapeutic response, starting with liver and expanding.
H1 Tags
Schema Types
What is Senseerahealth's revenue?
Who works at Senseerahealth?
Loading leads...
What do customers think of Senseerahealth?
No Trustpilot reviews available for this company.
Frequently Asked Questions about Senseerahealth
What is Senseerahealth's Revenue?
What does Senseerahealth do?
How fast is Senseerahealth growing?
What technologies does Senseerahealth use?
Who are Senseerahealth's competitors?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
How to contact Senseerahealth?
Contact Information
Export senseerahealth.com Data
Download the complete tech stack, analytics, leads, and company data for senseerahealth.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About senseerahealth.com
First-in-class liquid biopsy based on cell-free chromatin analysis, generating quantitativegenome expression maps to uncover disease stage and therapeutic response, starting with liver and expanding.
Company Overview
senseerahealth.com Social Media
Contact senseerahealth.com
Email Addresses
Phone Numbers
Technology Stack
senseerahealth.com uses 13 technologies across their website including Font Awesome, Adobe Fonts, PHP, WordPress, and more.
Fonts
Font Awesome, Adobe Fonts, Google Fonts
Programming Languages
PHP
CMS
WordPress
Privacy & Consent
Complianz
Performance
Lazy Loading
Web Standards
Twitter Cards
Traffic & Audience
senseerahealth.com receives approximately 0 monthly visitors. The website has a bounce rate of 0% with visitors viewing an average of 0.0 pages per visit. Users spend an average of 0:00 on the site.
Frequently Asked Questions
What is senseerahealth.com?
What technologies does senseerahealth.com use?
How do I contact senseerahealth.com?
What are senseerahealth.com's social media accounts?
How popular is senseerahealth.com?
Related Searches
This page provides publicly available information about senseerahealth.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit senseerahealth.com directly at https://senseerahealth.com.